A Study to Evaluate the Safety and Efficacy of Oral Nizubaglustat (AZ-3102) in Late-infantile and Juvenile Forms of GM1 Gangliosidosis or GM2 Gangliosidosis

Clinical trial NCT07082543 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT07082543
Sponsor: Azafaros B.V.
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Gangliosidoses, GM2 Gangliosidosis, GM1

Start date: 2025-06-30
Primary completion: 2028-02-06
Enrollment: 75

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.